Quick links

Secure login

Secure file transfer protocol

Register or renew user

Contact us

Trouble logging in? Forgot password? We can help!

philavax@phila.gov

215-685-6784

215-238-6944

Register a clinic

Fill out both forms, then either email or fax them to us at the contact above.

Clinic registration form
Enity confidentiality form

On behalf of patients

Patient update request

Looking for something else?

PhilaVax program info
Flat file reporting guide
More PhilaVax resources

VFC

New Vaccine Product Available for VFC/VFAAR A one-vial presentation of Menveo (MenACYW-135) is now available through the Philadelphia VFC & VFAAR programs. This presentation does not require reconstitution. The Prescribing Information now describes both presentations of Menveo: the current two-vial presentation and a new one-vial presentation.  One-vial Presentation (NEW)  NDC: 58160-0827-30  For use in individuals 10 years through...

12 September, 2023

Private COVID-19 Vaccine Procurement  Commercialization of COVID-19 vaccines is occurring next week. VFC Providers are required to match vaccines on the private side. We have created an FAQ to assist providers through this transition.  Take these steps now to plan which COVID-19 vaccines you will purchase privately:  Review the anticipated...

07 September, 2023

[vc_row][vc_column][vc_column_text] New Vaccine Product Available Through VFC: Prevnar 20 On June 27, 2023, the CDC approved Prevnar 20 (PCV20) for use in pediatric patients. Beginning September 6, 2023, this Prevnar 20 is available to order for your VFC eligible patients. The Prevnar 13 (PCV13) is no longer...

06 September, 2023

Recap: RSV Immunization in Outpatient Settings Thank you to those who attended the RSV townhall for nirsevimab (Beyfortus) immunization in outpatient settings on Tuesday, August 29! In case you missed it, please review important information below:  PDPH townhall presentation slides PDPH townhall meeting recording Nirsevimab FAQ Nirsevimab planning checklist Nirsevimab will...

31 August, 2023

Integrating RSV Immunization into EHR Systems RSV immunization will be available to order through the Vaccines for Children (VFC) program this fall. This newly approved monoclonal antibody, nirsevimab (Beyfortus), will be used to protect newborns and infants born during or entering their first RSV season.As your facility will likely...

30 August, 2023

Recap: RSV Immunization in Inpatient Settings Thank you to those who attended the RSV townhall for nirsevimab (Beyfortus) immunization in inpatient settings on Friday, August 24! In case you missed it, please review important information below: PDPH townhall presentation slides PDPH townhall meeting recording Nirsevimab FAQ Nirsevimab planning checklist Nirsevimab will...

29 August, 2023

RSV Townhall to Discuss Nirsevimab Come learn about the newly approved monoclonal antibody, nirsevimab (Beyfortus), to prevent RSV in neonates and young infants at a townhall hosted by the Philadelphia Immunization Program.  The townhall will take place over Zoom on Tuesday August 29 at 12pm. Nirsevimab will be...

23 August, 2023

VFC & VFAAR Flu Ordering Will Open 8/28/23 VFC & VFAAR providers can order flu for the 2023-24 season starting Monday, 8/28/23. Make sure your site is ready! Account for any unused 2022-23 VFC/VFAAR flu vaccine still at your site using PhilaVax: Process a return for the unopened...

23 August, 2023

Back-to-School Immunization Resources The PDPH Immunization Program and the School District of Philadelphia (SDP) want to remind you that now is the time to prepare your patients for back-to-school. Pennsylvania law requires all students (K-12) to be vaccinated while attending school. Students that do not have...

03 August, 2023

COVID-19 Vaccine Commercialization COVID-19 vaccine will soon be available for purchase on the commercial market and will be available to order through the Vaccines for Children (VFC) Program. We have created an FAQ and will host town halls to help with this transition. Commercialization of COVID-19 vaccines will transition...

02 August, 2023